JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2023, Vol. 25 ›› Issue (5): 577-585.DOI: 10.3969/j.issn.1671-2587.2023.05.001
Received:
2023-10-09
Online:
2023-10-20
Published:
2023-11-20
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.lcsxyjy.com/EN/10.3969/j.issn.1671-2587.2023.05.001
[1] KULDANEK S A,KELHER M,SILLIMAN C C.Risk factors,management and prevention of transfusion-related acute lung injury:a comprehensive update[J].Expert Rev Hematol,2019,12(9):773-785. [2] VLAAR A,KLEINMAN S.An update of the transfusion-related acute lung injury (TRALI) definition[J].Tjh,2019,36(4):282-283. [3] VLAAR A P J,KLEINMAN S.An update of the transfusion-related acute lung injury (TRALI):a proposed modified definition and classification scheme definition[J].Indian J Hematol Blood Transfus,2020,36(3):556-558. [4] MÜLLER MARCELLA C A,DANIELLE V S,BINNEKADE JAN M,et al.Low-risk transfusion-related acute lung injury donor strategies and the impact on the onset of transfusion-related acute lung injury:a meta-analysis[J].Transfusion,2015,55(1):164-75. [5] FOOD AND DRUG ADMINISTRATION.Fatalities Reported to FDA Following Blood Collection and Transfusion Annual Summary for FY2021.[EB/OL].(2023-09-25) [2022-10-24].https://www.fda.gov/media/172382/download?attachment. [6] VLAAR ALEXANDER P J,PEARL T,MARK F,et al.A consensus redefinition of transfusion-related acute lung injury[J].Transfusion,2019,59(7):2465-2476. [7] MAGOON R,WALIAN A,KOHLI J K,et al.Characterisin g TRALI:newer insights![J].Anaesth Crit Care Pain Med,2020,39(5):635-636. [8] VAN WONDEREN S F,KLANDERMAN R B,VLAAR A P J.Understanding transfusion-related acute lung injury (TRALI) and its complex pathophysiology[J].Blood Transfus,2022,20(6):443-445. [9] ZEEUW VAN DER LAAN EAN, VAN DER VELDEN S, PORCELIJN L, et al.Update on the pathophysiology of transfusion-related acute lung injury[J].Curr Opin Hematol.2020; 27(6):386-391. [10] TOY P.Update on transfusion-related acute lung injury[J].Clin Adv Hematol Oncol,2019,17(7):378-381. [11] DE CLIPPEL D,EMONDS M P,COMPERNOLLE V.Are we underestimating reverse TRALI?[J].Transfusion,2019,59(9):2788-2793. [12] PETERS A L,VAN DE WEERDT E K,PRINSZE F,et al.Donor characteristics do not influence transfusion-related acute lung injury incidence in a secondary analysis of two case-control studies[J].Transfus Clin Biol,2019,26(1):10-17. [13] TUNG J P,CHIARETTI S,DEAN M M,et al.Transfusion-related acute lung injury (TRALI):potential pathways of development,strategies for prevention and treatment,and future research directions[J].Blood Rev,2022,53:100926. [14] MIDDELBURG RUTGER A,DANIËLLE V S,ERNEST B,et al.The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury:a systematic review[J].Transfusion,2008,48(10):2167-76. [15] CAO,JIA,ZHU.BNP and NT-proBNP as diagnostic biomarkers for cardiac dysfunction in both clinical and forensic medicine[J].Int J Mol Sci,2019,20(8):1820. [16] CUNNINGHAM J W,MYHRE P L.NT-proBNP response to HeartFailureTherapies[J].J Am Coll Cardiol,2021,78(13):1333-1336. [17] FARNSWORTH C W,BAILEY A L,JAFFE A S,et al.Diagnostic concordance between NT-proBNP and BNP for suspected heart failure[J].Clin Biochem,2018,59:50-55. [18] CENTERS FOR DISEASE CONTROL AND PREVENTION.National healthcare safety network biovigilance component haemovigilance module surveillance protocol (V2.8).[EB/OL].(2023-02-06)[2023-10-24].https://www.cdc.gov/nhsn/pdfs/biovigilance/bv-hv-protocol-current.pdf. [19] INTERNATIONAL SOCIETY OF BLOOD TRANSFUSION WORKING PARTY ON HAEMOVIGILANCE.Transfusion-associated circulatory overload (TACO) definition(2018).[EB/OL].(2019-05-01)[2023-10-24].https://www.isbtweb.org/resource/tacodefinition.html. [20] STORCH E K,HILLYER C D,SHAZ B H.Spotlight on pathogenesis of TRALI:HNA-3a (CTL2) antibodies[J].Blood,2014,124(12):1868-1872. [21] BERTHOLD T,SCHUBERT N,MUSCHTER S,et al.HNA antibody-mediated neutrophil aggregation is dependent on serine protease activity[J].Vox Sang,2015,109(4):366-74. [22] VAN STEIN D,BECKERS E A M,PETERS A L,et al.Underdiagnosing of antibody-mediated transfusion-related acute lung injury:evaluation of cellular-based versus bead-based techniques[J].Vox Sang,2016,111(1):71-8. [23] SOUTAR R,MCSPORRAN W,TOMLINSON T,et al.Guideline on the investigation and management of acute transfusion reactions[J].Br J Haematol,2023,201(5):832-844. [24] ANANI W,TRIULZI D,YAZER M H,et al.Relative IgA-deficient recipients have an increased risk of severe allergic transfusion reactions[J].Vox Sang,2014,107(4):389-392. [25] GERTZ M A.Updates on the diagnosis and management of cold autoimmune hemolytic Anemia[J].Hematol Oncol Clin North Am,2022,36(2):341-352. [26] IACOPUCCI A P M,DA SILVA PEREIRA P,PEREIRA D A,et al.Intravascular hemolysis leads to exaggerated corpus cavernosum relaxation:implication for priapism in sickle cell disease[J].FASEB J,2022,36(10): e22535. [27] SAYLOR D M,BUEHLER P W,BROWN R P,et al.Predicting plasma free hemoglobin levels in patients due to medical device-related hemolysis[J].ASAIO J,2019,65(3):207-218. [28] SEMPLE J W,REBETZ J,KAPUR R.Transfusion-associated circulatory overload and transfusion-related acute lung injury[J].Blood,2019,133(17):1840-1853. [29] VAN DEN AKKER T A,GRIMES Z M,FRIEDMAN M T.Transfusion-associated circulatory overload and transfusion-related acute lung injury:a review of underreported entities with current updates[J].Am J Clin Pathol,2021,156(4):529-539. [30] YOKOYAMA A,SAKAMOTO Y,JO T,et al.Pulmonary disease as a risk factor for transfusion-related acute lung injury[J].ERJ Open Res,2021,7(3):00039-02021. [31] AUBRON C,HOURMANT B,MENGUY J,et al.Transfusion-related respiratory complications in intensive care:a diagnosis challenge[J].Transfus Clin Biol,2021,28(4):344-348. [32] MARCHIORI E,HOCHHEGGER B,ZANETTI G.Transfusion-related acute lung injury:an uncommon cause of pulmonary edema[J].J Bras Pneumol,2023:e20230175. [33] BLUMBERG N,HEAL J M,GETTINGS K F,et al.An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions[J].Transfusion,2010,50(12):2738-2744. [34] SILLIMAN C C,MOORE E E,KELHER M R,et al.Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury[J].Transfusion,2011,51(12):2549-2554. [35] EDER A F,DY B A,PEREZ J M,et al.The residual risk of transfusion-related acute lung injury at the American Red Cross (2008-2011):limitations of a predominantly male-donor plasma mitigation strategy[J].Transfusion,2013,53(7):1442-1449. [36] EDER A F,HERRON R M,STRUPP A,et al.Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006-2008)[J].Transfusion,2010,50(8):1732-1742. [37] LOH Y S,TAN S,KWOK M,et al.Reduction of biological response modifiers in the supernatant of washed paediatric red blood cells[J].Vox Sang,2016,111(4):365-373. [38] KLANDERMAN R B,BULLE E B,HEIJNEN J W M,et al.Reported transfusion-related acute lung injury associated with solvent/detergent plasma - A case series[J].Transfusion,2022,62(3):594-599. [39] YU Y H,LIAN Z Q.Update on transfusion-related acute lung injury:an overview of its pathogenesis and management[J].Front Immunol,2023,14:1175387. [40] PEGLER J R M,CASTRO A P B M,PASTORINO A C,et al.Transfusion-related acute lung injury associated to intravenous immunoglobulin infusion in a pediatric patient[J].Einstein Sao Palo Braz,2020,18:eRC5606. [41] IBRAHIM J,AL AMRI A,GHATASHEH G.Transfusion-related acute lung injury after immunoglobulin infusion for Kawasaki disease:a case report and literature review[J].Glob Pediatr Heath,2017,4:2333794X1774654. [42] BAUDEL J L,VIGNERON C,PRAS-LANDRE V,et al.Transfusion-related acute lung injury (TRALI) after intravenous immunoglobulins:French multicentre study and literature review[J].Clin Rheumatol,2020,39(2):541-546. [43] 急诊氧气治疗专家共识组.急诊氧气治疗专家共识[J].中华急诊医学杂志,2018,27(4):355-360. [44] YANG Z G,LEI X L,LI X L.Early application of low-dose glucocorticoid improves acute respiratory distress syndrome:a meta-analysis of randomized controlled trials[J].Exp Ther Med,2017,13(4):1215-1224. [45] 付涌水,主编.临床输血[M].第3版.北京:人民卫生出版社,2013:293-294. [46] VAN DER GOES M C,JACOBS J W,BIJLSMA J W.The value of glucocorticoid co-therapy in different rheumatic diseases - positive and adverse effects[J].Arthritis Res Ther,2014,16(2):1-13. [47] CAPLAN A,FETT N,ROSENBACH M,et al.Prevention and management of glucocorticoid-induced side effects:a comprehensive review[J].J Am Acad Dermatol,2017,76(1):1-9. [48] PETERS A L,VAN STEIN D,VLAAR A P J.Antibody-mediated transfusion-related acute lung injury;from discovery to prevention[J].Br J Haematol,2015,170(5):597-614. [49] STRAIT R T,HICKS W,BARASA N,et al.MHC class I-specific antibody binding to nonhematopoietic cells drives complement activation to induce transfusion-related acute lung injury in mice[J].J Exp Med,2011,208(12):2525-2544. [50] KAPUR R,KIM M,ASLAM R,et al.T regulatory cells and dendritic cells protect against transfusion-related acute lung injury via IL-10[J].Blood,2017,129(18):2557-2569. [51] TUINMAN P R,VLAAR A P,BINNENKADE J M,et al.The effect of aspirin in transfusion-related acute lung injury in critically ill patients[J].Anaesthesia,2012,67(6):594-599. [52] 葛均波,徐永健,主编.内科学[M].第8版.北京:人民卫生出版社,2013:138-144. [53] ISHIDA Y,NAKAZAWA K,ITABASHI T,et al.Transfusion-related acute lung injury under general anesthesia successfully treated with extracorporeal membrane oxygenation:a case report[J].Clin Case Rep,2023,11(5): e7386. [54] 中国医师协会呼吸医师分会危重症医学专业委员会,中华医学会呼吸病学分会危重症医学学组.体外膜式氧合治疗成人重症呼吸衰竭推荐意见[J].中华结核和呼吸杂志,2019,42(9):660-684. [55] TONNA J E,ABRAMS D,BRODIE D,et al.Management of adult patients supported with venovenous extracorporeal membrane oxygenation (VV ECMO):guideline from the extracorporeal life support organization (ELSO)[J].ASAIO J,2021,67(6):601-610. |
[1] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(5): 586-593. |
[2] | FENG Na, LAN Jing, CAO Xin, et al. A Comparative Study on the Effect of X-ray and γ-ray Irradiation on the Quality of Suspended Red Blood Cells [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(5): 594-598. |
[3] | QIAO Jian, DIAO Chunhong, YU Yang, et al. Evodiamine Alleviates Blood Transfusion Related Acute Lung Injury in Rats by Regulating HMGB1/TLR4/NF-κB Signaling Pathway [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(5): 599-606. |
[4] | WANG Xiaohuan, GUO Kai, LIU Qian, et al. Century Clot: Clinical Application of Coagulation Function in Children with Kawasaki Disease [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(5): 607-612. |
[5] | CHEN Tingting, ZHAO Likun, ZHUO Hailong, et al. Expression of CD38 in Different Blood Groups during Different Preservation Periods [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(5): 613-618. |
[6] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(5): 619-624. |
[7] | LIU Hui, ZHUO Hailong, LUO Qun. Daratumomab Interference in Polybrene Test Due to IgG Anti-D Antibody [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(5): 625-630. |
[8] | LIU Zheng, SUN Yamin, SHAO Shujun, et al. Analysis of HLA-I Antibody Specificity in Patients with Platelet Transfusion Refractoriness [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(5): 631-635. |
[9] | MA Yintu, WANG Fenghong, YANG Xiaoya, et al. Technology Design and Development of the Plasma Collector and Lines Integration with Multiple Blood Therapy [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(5): 636-640. |
[10] | HUA Minyu, DING Yueping, WANG Zhenxing, et al. Influence of COVID-19 Epidemic on the Collection and Supply of Apheresis Platelets in Prefecture-Level Blood Stations in China [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(5): 641-647. |
[11] | ZHOU Zhenyu, HUANG Xiangyan. Auxiliary Steel Plate Combined with Platelet Rich Plasma for the Treatment of Femoral Shaft Nonunion after Intramedullary Nail Fixation [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(5): 648-653. |
[12] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(5): 673-677. |
[13] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(5): 685-687. |
[14] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(5): 688-691. |
[15] | LI Bo, ZENG Xianglong. Research Progress in Iron Deficiency among Blood Donors [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(5): 699-705. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||